NCT02174211View on ClinicalTrials.gov

A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Ranibizumab

Intravitreal injection of ranibizumab

DRUG

Aflibercept

Intravitreal injection of aflibercept

Trial Locations (1)

SE5 9RS

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
collaborator

King's College London

OTHER

lead

King's College Hospital NHS Trust

OTHER

NCT02174211 - A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. | Biotech Hunter | Biotech Hunter